Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$211,307
+$211,307 QoQ
Shares Held
3,206
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Sep 30, 2024CallValue
$1,874,400
CallShares
35,500
PutValue
$818,400
PutShares
15,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GTS SECURITIES LLC holds $5,249,889 across 19 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,164 | $1,079,924 | |
| 2 | GMAB |
Genmab A/S
|
32,116 | $882,226 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,060 | $526,533 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,452 | $437,095 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
|
25,320 | $430,440 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
35,537 | $409,741 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
626 | $390,336 | |
| 8 | BHVN |
Biohaven Ltd.
|
16,988 | $252,781 |
All Filings in CYTK
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $211,307 | 3,206 | Shares | Defined | 2026-05-15 | |
| 2024-09-30 | $1,874,400 | 35,500 | Call | Defined | 2024-11-13 | |
| 2024-09-30 | $818,400 | 15,500 | Put | Defined | 2024-11-13 | |
| 2024-06-30 | $1,018,584 | 18,800 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $12,290,283 | 175,300 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $15,073,650 | 215,000 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $56,013,441 | 670,900 | Put | Defined | 2024-02-15 | |
| 2023-12-31 | $9,760,064 | 116,901 | Shares | Defined | 2024-02-15 | |
| 2023-12-31 | $23,836,395 | 285,500 | Call | Defined | 2024-02-15 | |
| 2023-09-30 | $300,492 | 10,200 | Call | Defined | 2023-11-15 | |
| 2023-09-30 | $211,758 | 7,188 | Shares | Defined | 2023-11-15 | |
| 2023-09-30 | $477,252 | 16,200 | Put | Defined | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||